Antibe Therapeutics Inc.
ATE
Rang in Aktien
#31889
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
Aktienkurs
$0.21483059
Zuletzt synchronisiert: 2024-05-07
Marktkapitalisierung
$11.13M
Veränderung (1 Tag)
0.34%
Veränderung (1 Jahr)
-0.36%
Land
CA
Handel Antibe Therapeutics Inc. (ATE)
Kategorie
Healthcare
Aktien-Split-Historie für Antibe Therapeutics Inc. (ATE)
Die Aktie Antibe Therapeutics Inc. (Symbol: ATE) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Oct 20, 2026 statt.
Eine ATE-Aktie, die vor dem Oct 20, 2026 gekauft wurde, entspricht heute 0 ATE-Aktien.
Der letzte Aktiensplit fand am Oct 20, 2026 statt.
Eine ATE-Aktie, die vor dem Oct 20, 2026 gekauft wurde, entspricht heute 0 ATE-Aktien.
Liste der Aktiensplits
| Jahr | Aktien-Split | Multiplikator | Kumulierter Multiplikator |
|---|---|---|---|
| Nicht genügend Daten für die angegebenen Daten. | |||
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
| Unternehmen | Anzahl der Aktiensplits | Kumulierter Multiplikator | Land |
|---|---|---|---|
| 9 | x285 |
US
|
|
| 7 | x127 |
IE
|
|
| 9 | x162 |
US
|
|
| 2 | x4 |
US
|
|
| 0 | - |
DE
|
